Biology of Demyelinating Diseases 575 Garbern JY (2005) Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system. J Neurol Sci 228:201–203 Garbern JY, Cambi F, Tang XM, Sima AA, Vallat JM, Bosch EP, Lewis R, Shy M, Sohi J, Kraft G, Chen KL, Joshi I, Leonard DG, Johnson W, Raskind W, Dlouhy SR, Pratt V, Hodes ME, Bird T, Kamholz J (1997) Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19:205–218 Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125: 551–561 Gatewood JD, Morgan MD, Eaton M, McNamara IM, Stevens LF, Macbeth AH, Meyer EA, Lomas LM, Kozub FJ, Lambert KG, Kinsley CH (2005) Motherhood mitigates aging-related decre- ments in learning and memory and positively affects brain aging in the rat. Brain R es Bull 66:91–98 Giaume C, Kirchhoff F, Matute C, Reichenbach A, Verkhratsky A (2007) Glia: the fulcrum of brain diseases. Cell Death Differ 14:1324–1335 Gieselmann V, Franken S, Klein D, Mansson JE, Sandhoff R, Lullmann Rauch R, Hartmann D, Saravanan VP, De Deyn PP, D’Hooge R, Van Der Linden AM, Schaeren-Wiemers N (2003) Metachromatic leukodystrophy: consequences of sulphatide accumulation. Acta Paediatr Suppl 92:74–79; discussion 45 Gillespie CS, Sherman DL, Blair GE, Brophy PJ (1994) Periaxin, a novel protein of myelinating Schwann cells with a possible role in axonal ensheathment. Neuron 12:497–508 Givogri MI, Costa RM, Schonmann V, Silva AJ, Campagnoni AT, Bongarzone ER (2002) Central nervous system myelination in mice with deficient expression of Notch1 receptor. J Neurosci Res 67:309–320 Goldberg JL, Barres BA (2000) Nogo in nerve regeneration. Nature 403:369–370 Gow A, Sharma R (2003) The unfolded protein response in protein aggregating diseases. Neuromolecular Med 4:73–94 Gow A, Southwood CM, Lazzarini RA (1998) Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925–934 Graham DI, Lantos PA (1997) Greenfield’s Neuropathology, 6th edn. Arnold, London Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S (2007) White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27:1812–1823 Hagemann TL, Connor JX, Messing A (2006) Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci 26:11162–11173 Hahn AF, Ainsworth PJ, Bolton CF, Bilbao JM, Vallat JM (2001) Pathological findings in the x- linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol (Berl) 101:129–139 Haroutunian VP, Davis KL (2007) Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia. Int J Neuropsychopharmacol 10:499–502 Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL (2007) Variations in oligodendrocyte- related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. Int J Neuropsychopharmacol 10:565–573 Hausler M, Anhuf D, Schuler H, Ramaekers VT, Thron A, Zerres K, Moller-Hartmann W (2005) White-matter disease in 18q deletion (18q-) syndrome: magnetic resonance spectroscopy indi- cates demyelination or increased myelin turnover rather than dysmyelination. Neuroradiology 47:83–86 Honke K, Hirahara Y, Dupree J, Suzuki K, Popko B, Fukushima K, Fukushima J, Nagasawa T, Yoshida N, Wada Y, Taniguchi N (2002) Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc Natl Acad Sci U S A 99:4227–4232 576 D. Pham-Dinh and N. Baumann Howell OW, Palser A, Polito A, Melrose S, Zonta B, Scheiermann C, Vora AJ, Brophy PJ, Reynolds R (2006) Disruption of neurofascin localization reveals early changes preceding demyelination and remyelination in multiple sclerosis. Brain 129:3173–3185 Ilyas AA, Chen ZW, Cook SD (2003) Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis. J Neuroimmunol 139:76–80 Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD (2006) Astrocytes promote myelination in response to electrical impulses. Neuron 49:823–832 Ishibashi T, Ding L, Ikenaka K, Inoue Y, Miyado K, Mekada E, Baba H (2004) Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation. J Neurosci 24:96–102 Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K, Nishino H, Baba H (2002) A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J Neurosci 22:6507–6514 Jagannathan NR, Tandon N, Raghunathan P, Kochupillai N (1998) Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. Brain Res Dev Brain Res 109:179–186 Jessen KR, Mirsky R (1991) Schwann cell precursors and their development. Glia 4:185–194 John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF (2002) Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115–1121 Jung-Testas I, Do Thi A, Koenig H, Desarnaud F, Shazand K, Schumacher M, Baulieu EE (1999) Progesterone as a neurosteroid: synthesis and actions in rat glial cells. J Steroid Biochem Mol Biol 69:97–107 Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, Oh L, Rasband M, Lappe-Siefke C, Yu K, Ornitz DM, Nave KA, Bansal R (2006) Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci 26:12339–12350 Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12: 138–143 Karadottir R, Attwell D (2007) Neurotransmitter receptors in the life and death of oligodendro- cytes. Neuroscience 145:1426–1438 Karim SA, Barrie JA, McCulloch MC, Montague P, Edgar JM, Kirkham D, Anderson TJ, Nave KA, Griffiths IR, McLaughlin M (2007) PLP-1 overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease. Glia 55:341–351 Karlsson KA, Samuelsson BE, Steen GO (1974) The lipid composition and Na+-K+-dependent adenosine-triphosphatase activity of the salt (nasal) gland of eider duck and herring gull. A role for sulphatides in sodium-ion transport. Eur J Biochem 46:243–258 Karoutzou G, Emrich HM, Dietrich DE (2007) The myelin-pathogenesis puzzle in schizophrenia: a literature review. Mol Psychiatry 13(3):245–260 Keirstead HS, Levine JM, Blakemore WF (1998) Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22: 161–170 Kubicki M, McCarley RW, Shenton ME (2005) Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry 18:121–134 Kuerten S, Kostova-Bales DA, Frenzel LP, Tigno JT, Tary-Lehmann M, Angelov DN, Lehmann PV (2007) MP4- and MOG:35–55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum. J Neuroimmunol 189:31–40 Kuerten S, Lichtenegger FS, Faas S, Angelov DN, Tary-Lehmann M, Lehmann PV (2006) MBP- PLP-1 fusion protein-induced EAE in C57BL/6 mice. J Neuroimmunol 177:99–111 Lalive PH, Menge T, Delarasse C, Della Gaspera B, Pham-Dinh D, Villoslada P, von Budingen HC, Genain CP (2006) Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Proc Natl Acad Sci U S A 103:2280–2285 Biology of Demyelinating Diseases 577 Larocque D, Richard S (2005) QUAKING KH domain proteins as regulators of glial cell fate and myelination. RNA Biol 2:37–40 Lassmann H (2004) Experimental autoimmune encephalomyelitis. In: LazzariniRA(ed) Myelin Biology and Disorders. Elsevier Academic Press, San Diego, CA, pp 1039–1071 Lazzarini R (2004) Myelin biology and disorders. Elsevier Academic Press, San Diego, CA Leegwater PA, Vermeulen G, Konst AA, Naidu S, Mulders J, Visser A, Kersbergen P, Mobach D, Fonds D, van Berkel CG, Lemmers RJ, Frants RR, Oudejans CB, Schutgens RB, Pronk JC, van der Knaap MS (2001) Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet 29:383–388 Ligon KL, Fancy SP, Franklin RJ, Rowitch DH (2006) Olig gene function in CNS development and disease. Glia 54:1–10 Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, Sherrington R, Adolfsson R, Jazin E (2001) A schizophrenia-susceptibility locus at 6q25, in one of the world’s largest reported pedigrees. Am J Hum Genet 69:96–105 Lopate G, Pestronk A, Evans S, Li L, Clifford D (2005) Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy. Neurology 64:1632–1634 Lubetzki C, Demerens C, Anglade P, Villarroya H, Frankfurter A, Lee VM, Zalc B (1993) Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci U S A 90: 6820–6824 Lubetzki C, Stankoff B (2000) Role of axonal signals in myelination of the central nervous system. Pathol Biol (Paris) 48:63–69 Lubetzki C, Williams A, Stankoff B (2005) Promoting repair in multiple sclerosis: problems and prospects. Curr Opin Neurol 18:237–244 Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest 39:597–612 Ludwin SK (1994) Central nervous system remyelination: studies in chronically damaged tissue. Ann Neurol 36(Suppl):S143–S145 Macklin WB, C ampagnoni CW, Deininger PL, Gardinier MV (1987) Structure and expression of the mouse myelin proteolipid protein gene. J Neurosci Res 18:383–394 Maier O, van der Heide T, Johnson R, de Vries H, Baron W, Hoekstra D (2006) The function of neurofascin155 in oligodendrocytes is regulated by metalloprotease-mediated cleavage and ectodomain shedding. Exp Cell Res 312:500–511 Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL (2006) Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53:372–381 Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK (2004) Oligodendrocytes and progenitors become progressively depleted within chronically demyeli- nated lesions. Am J Pathol 164:1673–1682 Mastronardi FG, Moscarello MA (2005) Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 80:301–308 Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107–116 Mattei MG, Alliel PM, Dautigny A, Passage E, Pham-Dinh D, Mattei JF, Jolles P (1986) The gene encoding for the major brain proteolipid (PLP-1) maps on the q-22 band of the human X chromosome. Hum Genet 72:352–353 Matute C (2006) Oligodendrocyte NMDA receptors: a novel therapeutic target. Trends Mol Med 12:289–292 McInnes LA, Lauriat TL (2006) RNA metabolism and dysmyelination in schizophrenia. Neurosci Biobehav Rev 30:551–561 Menichella DM, Goodenough DA, Sirkowski E, Scherer SS, Paul DL (2003) Connexins are critical for normal myelination in the CNS. J Neurosci 23:5963–5973 Menn B, Garcia-Verdugo JM, Yaschine C, Gonzalez-Perez O, Rowitch D, Alvarez-Buylla A (2006) Origin of oligodendrocytes in the subventricular zone of the adult brain. J Neurosci 26: 7907–7918 578 D. Pham-Dinh and N. Baumann Meyer zu Horste G, Prukop T, Nave KA, Sereda MW (2006) Myelin disorders: causes and perspectives of Charcot-Marie-Tooth neuropathy. J Mol Neurosci 28:77–88 Mi S, Hu B, Hahm K, Luo Y, Kam Hui ESZ, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Perpinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W (2007) Lingo-1 antagnonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental auto-immune encephalomyelitis. Nat Med 13:1228–3123 Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB (2005) LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8: 745–751 Michailov GV, Sereda MW, Brinkmann BG, Fischer TM, Haug B, Birchmeier C, Role L, Lai C, Schwab MH, Nave KA (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304:700–703 Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D (2004) Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell Mol Life Sci 61:369–385 Mignot C, Delarasse C, Escaich S, Della Gaspera B, Noe E, Colucci-Guyon E, Babinet C, Pekny M, Vicart P, Boespflug-Tanguy O, Dautigny A, Rodriguez D, Pham-Dinh D (2007) Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Exp Cell Res 313:2766–2779 Mignot C, Desguerre I, Burglen L, Hertz-Pannier L, Renaldo F, Gadisseux JF, Gallet S, Pham-Dinh D, Boespflug-Tanguy O, Rodriguez D (2009) Tumor-like enlargement of the optic chiasm in an infant with Alexander disease. Brain Dev 31:244–247 Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM (2007) N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 81:89–131 Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361:726–730 Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A (2007) Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 104:4694–4699 Nie DY, Ma QH, Law JW, Chia CP, Dhingra NK, Shimoda Y, Yang WL, Gong N, Chen QW, Xu G, Hu QD, Chow PK, Ng YK, Ling EA, Watanabe K, Xu TL, Habib AA, Schachner M, Xiao ZC (2006) Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glia Biol 2:151–164 Nishiyama A, Chang A, Trapp BD (1999) NG2+ glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 58:1113–1124 Oberheim NA, Wang X, Goldman S, Nedergaard M (2006) Astrocytic complexity distinguishes the human brain. Trends Neurosci 29:547–553 Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, Scherer SS, Campbell KP, Moore SA, Chen ZL, Strickland S, Di Muzio A, Uncini A, Wrabetz L, Feltri ML (2005) Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci 25:9418–9427 Ogawa Y, Schafer DP, Horresh I, Bar V, Hales K, Yang Y, Susuki K, Peles E, Stankewich MC, Rasband MN (2006) Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. J Neurosci 26:5230–5239 Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS (2007) Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Mol Cell Neurosci 34:629–641 Owens GC, Bunge RP (1989) Evidence for an early role for myelin-associated glycoprotein in the process of myelination. Glia 2:119–128 Park SK, Miller R, Krane I, Vartanian T (2001a) The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J Cell Biol 154:1245–1258 Biology of Demyelinating Diseases 579 Park SK, Solomon D, Vartanian T (2001b) Growth factor control of CNS myelination. Dev Neurosci 23:327–337 Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontes M (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 10:396–401 Peles E, Salzer JL (2000) Molecular domains of myelinated axons. Curr Opin Neurobiol 10: 558–565 Pham-Dinh D, Dautigny A, Linington C (2004) The myelin/oligodendrocyte glycoprotein (MOG): structure and physiopathological functions. In: LazzariniRA(ed) Myelin Biology and Disorders. Elsevier Academic Press, San Diego, CA, pp 469–498 Pham-Dinh D, Mattei MG, Nussbaum JL, Roussel G, Pontarotti P, Roeckel N, Mather IH, Arzt K, Lindahl KF, Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci U S A 90:7990–7994 Picard-Riera N, Decker L, Delarasse C, Goude K, Nait-Oumesmar B, Liblau R, Pham-Dinh D, Barron van Evercooren A (2002) Experimental autoimmune encephalomyelitis mobilizes neu- ral progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci U S A 99:13211–13216 Pittock SJ, Reindl M, Achenbach S, Berger T, Bruck W, Konig F, Morales Y, Lassmann H, Bryant S, Moore SB, Keegan BM, Lucchinetti CF (2007) Myelin oligodendrocyte glycoprotein anti- bodies in pathologically proven multiple sclerosis: frequency, stability and clinicopathologic correlations. Mult Scler 13:7–16 Powers JM (2005) Demyelination in peroxisomal diseases. J Neurol Sci 228:206–207 Pujol JC, Soriano-Mas H, Ortiz N, Sebastian-Galles JM, Losilla JM, Deus J (2006) Myelination of language-related areas in the developing brain. Neurology 66:339–343 Quarles RH (2007) Myelin-associated glycoprotein (MAG): past, present and beyond. J Neurochem 100:1431–1448 Quinlan RA, Brenner M, Goldman JE, Messing A (2007) GFAP and its role in Alexander disease. Exp Cell Res 313:2077–2087 Raine CS, Traugott U, Farooq M, Bornstein MB, Norton WT (1981) Augmentation of immune- mediated demyelination by lipid haptens. Lab Invest 45:174–182 Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave KA, Bansal R (2005) CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 50: 86–90 Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, Turpin JC, Lefevre M, Olivier C, Tardieu S, Krivit W, Moser H, Moser A, Gieselmann V, Zalc B, Cox T, Reuner U, Tylki-Szymanska A, Aboul-Enein F, LeGuern E, Bernheimer H, Berger J (2006) Late- onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology 67: 859–863 Regenold WT, Phatak P, Marano CM, Gearhart L, Viens CH, Hisley KC (2007) Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 151:179–188 Roach A, Boylan K, Horvath S, Prusiner SB, Hood LE (1983) Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34:799–806 Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N’Guyen S, Goizet C, Gelot A, Surtees R, Pedespan JM, Hernandorena X, Troncoso M, Uziel G, Messing A, Ponsot G, Pham-Dinh D, Dautigny A, Boespflug-Tanguy O (2001) Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet 69:1134–1140 Rodriguez D, Gelot A, Della Gaspera B, Robain O, Ponsot G, Sarlieve LL, Ghandour S, Pompidou A, Dautigny A, Aubourg P, Pham-Dinh D (1999) Increased density of oligodendrocytes in childhood ataxia with diffuse central hypomyelination (CACH) syndrome: neuropathological and biochemical study of two cases. Acta Neuropathol (Berl) 97:469–480 580 D. Pham-Dinh and N. Baumann Rogister B, Ben-Hur T, Dubois-Dalcq M (1999) From neural stem cells to myelinating oligoden- drocytes. Mol Cell Neurosci 14:287–300 Rosenbluth J, Nave KA, Mierzwa A, Schiff R (2006) Subtle myelin defects in PLP-1-null mice. Glia 54:172–182 Rosenbluth J, Schiff R, Liang WL, Dou W (2003) Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma. J Neurocytol 32:265–276 Roy K, Murtie JC, El-Khodor BF, Edgar N, Sardi SP, Hooks BM, Benoit-Marand M, Chen C, Moore H, O’Donnell P, Brunner D, Corfas G (2007) Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders. Proc Natl Acad Sci U S A 104:8131–8136 Saravanan K, Schaeren-Wiemers N, Klein D, Sandhoff R, Schwarz A, Yaghootfam A, Gieselmann V, Franken S (2004) Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorder. Neurobiol Dis 16: 396–406 Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter U (2004) The raft-associated protein MAL is required for maintenance of proper axon–glia interactions in the central nervous system. J Cell Biol 166:731–742 Scherer SS, Deschenes SM, Xu YT, Grinspan JB, Fischbeck KH, Paul DL (1995) Connexin32 is a myelin-related protein in the PNS and CNS. J Neurosci 15:8281–8294 Schiffmann R, Elroy-Stein O (2006) Childhood ataxia with CNS hypomyelination/vanishing white matter disease – a common leukodystrophy caused by abnormal control of protein synthesis. Mol Genet Metab 88:7–15 Schumacher M, Guennoun R, Stein DG, De Nicola AF (2007) Progesterone: therapeutic opportu- nities for neuroprotection and myelin repair. Pharmacol Ther 116:77–106 Seldon HL (2007) Extended neocortical maturation time encompasses speciation, fatty acid and lateralization theories of the evolution of schizophrenia and creativity. Med Hypotheses 69(5):1085–1089 Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 9:1533–1537 Shy ME (2004) Charcot-Marie-Tooth disease: an update. Curr Opin Neurol 17:579–585 Shy ME, Jani A, Krajewski K, Grandis M, Lewis RA, Li J, Shy RR, Balsamo J, Lilien J, Garbern JY, Kamholz J (2004) Phenotypic clustering in MPZ mutations. Brain 127: 371–384 Simons M, Trajkovic K (2006) Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J Cell Sci 119:4381–4389 Smith EJ, Blakemore WF, McDonald WI (1979) Central remyelination restores secure conduction. Nature 280:395–396 Southwood CM, Garbern J, Jiang W, Gow A (2002) The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585–596 Sow A, Lamant M, Bonny JM, Larvaron P, Piaud O, Lecureuil C, Fontaine I, Saleh MC, Garcia Otin AL, Renou JP, Baron B, Zakin M, Guillou F (2006) Oligodendrocyte differentiation is increased in transferrin transgenic mice. J Neurosci Res 83:403–414 Spencer T, Domeniconi M, Cao Z, Filbin MT (2003) New roles for old proteins in adult CNS axonal regeneration. Curr Opin Neurobiol 13:133–139 Spiegel I, Peles E (2006) A new player in CNS myelination. Neuron 49:777–778 Stangel M, Hartung HP (2002) Remyelinating strategies for the treatment of multiple sclerosis. Prog Neurobiol 68:361–376 Staugaitis SM, Smith PR, Colman DR (1990) Expression of myelin basic protein isoforms in nonglial cells. J Cell Biol 110:1719–1727 Steinman L (2001) Blockade of gamma interferon might be beneficial in MS. Mult Scler 7: 275–276 Biology of Demyelinating Diseases 581 Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60:12–21 Stevens B (2006) Cross-talk between growth factor and purinergic signalling regulates Schwann cell proliferation. Novartis Found Symp 276:162–175; discussion 175–80, 233–237, 275–81 Stevens B, Fields RD (2000) Response of Schwann cells to action potentials in development. Science 287:2267–2271 Stevens B, Ishibashi T, Chen JF, Fields RD (2004) Adenosine: an activity-dependent axonal sig- nal regulating MAP kinase and proliferation in developing Schwann cells. Neuron Glia Biol 1:23–34 Stevens B, Porta S, Haak LL, Gallo V, Fields RD (2002) Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:855–868 Stewart DG, Davis KL (2004) Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. Int Rev Neurobiol 59:381–424 Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJ (2004) Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 127:1928–1941 Suzuki K (2003) Globoid cell leukodystrophy (Krabbe’s disease): update. J Child Neurol 18: 595–603 Suzuki K, Kikkawa Y (1969) Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone). Am J Pathol 54:307–325 Tanaka KF, Takebayashi H, Yamazaki Y, Ono K, Naruse M, Iwasato T, Itohara S, Kato H, Ikenaka K (2007) Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia 55:617–631 Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681–694 Teijido O, Casaroli-Marano R, Kharkovets T, Aguado F, Zorzano A, Palacin M, Soriano E, Martinez A, Estevez R (2007) Expression patterns of MLC1 protein in the central and peripheral nervous systems. Neurobiol Dis 26:532–545 Terada N, Baracskay K, Kinter M, Melrose S, Brophy PJ, Boucheix C, Bjartmar C, Kidd G, Trapp BD (2002) The tetraspanin protein, CD9, is expressed by progenitor cells commit- ted to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2. Glia 40: 350–359 Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, Kang J, Nedergaard M (2005) An astrocytic basis of epilepsy. Nat Med 11:973–981 Tian DS, Dong Q, Pan DJ, He Y, Yu ZY, Xie MJ, Wang W (2007) Attenuation of astrogliosis by suppressing of microglial proliferation with the cell cycle inhibitor olomoucine in rat spinal cord injury model. Brain Res 1154:206–214 Tian R, Gregor M, Wiche G, Goldman JE (2006) Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am J Pathol 168:888–897 Tiwari-Woodruff S, Beltran-Parrazal L, Charles A, Keck T, Vu T, Bronstein J (2006) K+ chan- nel KV3.1 associates with OSP/claudin-11 and regulates oligodendrocyte development. Am J Physiol Cell Physiol 291:C687–C698 Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M, Nicoletti F, Pozzilli C (2005) Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 76:272–275 Tominaga K, Matsuda J, Kido M, Naito E, Yokota I, Toida K, Ishimura K, Suzuki K, Kuroda Y (2004) Genetic background markedly influences vulnerability of the hippocampal neuronal organization in the “twitcher” mouse model of globoid cell leukodystrophy. J Neurosci Res 77:507–516 Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, Havaki S, Iwakura Y, Fukamauchi F, Watanabe K, Soliven B, Girault JA, Karagogeos D (2003) Association of TAG-1 with Caspr2 582 D. Pham-Dinh and N. Baumann is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162:1161–1172 Trapp BD, Pfeiffer SE, Anitei M, Kidd G (2004) Cell biology of myelin assembly. In: Lazzarini RA et al (eds) Myelin biology and disorders. Elsevier Academic Press, New York, NY, pp 29–55 Turpin JC, Jouas M, Sereni C, Pluot M, Baumann N (1985) Révélation à l’âge adulte d’un cas d’adrénoleucodystrophie familiale. Rev Neurol 141:289–295 Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg- Didinger G, Aksu F, Topaloglu H, Nurnberg P, Hubner C, Weschke B, Gartner J (2004) Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus- Merzbacher-like disease. Am J Hum Genet 75:251–260 Vesce S, Rossi D, Brambilla L, Volterra A (2007) Glutamate release from astrocytes in physiologi- cal conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 82:57–71 Voas MG, Lyons DA, Naylor SG, Arana N, Rasband MN, Talbot WS (2007) alphaII-spectrin is essential for assembly of the nodes of Ranvier in myelinated axons. Curr Biol 17: 562–568 von Budingen HC, Hauser SL, Ouallet JC, Tanuma N, Menge T, Genain CP (2004) Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences dis- ease phenotype and antibody effector functions in autoimmune demyelination. Eur J Immunol 34:2072–2083 von Budingen HC, Menge T, Hauser SL, Genain CP (2006) Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis. Immunogenetics 58:122–128 Waxman SG, Bangalore L (2003) Electrophysiological consequences of myelination. In: Lazzarini, RA et al (eds) Myelin Biology and Disorders. Academic Press, New York, NY, pp 117–142 Weimbs T, Stoffel W (1992) Proteolipid protein (PLP-1) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP-1. Biochemistry 31:12289–12296 Williams A, Piaton G, Aigrot MS, Belhadi A, Théaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C (2007b) Semaphorin A and 3F, key players in myelin repair in multiple sclerosis? Brain 130:2554–2565 Williams A, Piaton G„ Lubetzki C (2007a) Astrocytes-friends or foes in multiple sclerosis? Glia 55:1300–1312 Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591–2625 Wilson HC, Scolding NJ, Raine CS (2006) Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 176:162–173 Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601–609 Woodruff RH, Franklin RJ (1999) Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 5:216–228 Xin M, Yue T, Ma Z, Wu FF, Gow A, Lu QR (2005) Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice. J Neurosci 25:1354–1365 Yakovlev PI, Lecours LA (1966) The myelinogenic cycles of regional maturation of the brain. BlacKwell, Oxford Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M (2004) Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A 101:11404–11409 Zalc B, Helwig JJ, Ghandour MS, Sarlieve L (1978) Sulfatide in the kidney: how is this lipid involved in sodium chloride transport? FEBS Lett 92:92–96 Biology of Demyelinating Diseases 583 Zeger M, Popken G, Zhang J, Xuan S, Lu QR, Schwab MH, Nave KA, Rowitch D, D’Ercole AJ, Ye P (2007) Insulin-like growth factor type 1 receptor signaling in the cells of oligodendro- cyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia 55:400–411 Zhao C, Fancy SP, Magy L, Urwin JE, Franklin RJ (2005) Stem cells, progenitors and myelin repair. J Anat 207:251–258 . Biology of Demyelinating Diseases 575 Garbern JY (2005) Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system. J. unfolded protein response in protein aggregating diseases. Neuromolecular Med 4:73–94 Gow A, Southwood CM, Lazzarini RA (1998) Disrupted proteolipid protein trafficking results in oligodendrocyte. Lomas LM, Kozub FJ, Lambert KG, Kinsley CH (2005) Motherhood mitigates aging-related decre- ments in learning and memory and positively affects brain aging in the rat. Brain R es Bull 66:91–98 Giaume